Streamlining your program from early phase development to commercialization, mitigating project risk and producing a quality medicine, Abzena is an industry leader in the development, scaling and manufacture of small molecule intermediates including high potency chemistry, payloads, linkers, payload-linker chemical intermediates, bioconjugation and Antibody Drug Conjugates (ADCs).
Wherever your molecule is in its development, we have the agility and capability to support technology transfer, process optimization, and full process development capabilities.
Whether you need assistance developing a new process, or improving existing processes, or preparing to manufacture your product, you will benefit from our in-depth expertise.
Get in touch